Dose escalation model for limited-stage small-cell lung cancer

This modeling suggests more aggressive treatment through escalation of dose-per-fraction, which may result in substantial gains in local PFS2year. This points towards treatment durations of 3 weeks as being optimal with a BID schedule predicting possible gains in local PFS2year at lower rates of expected late complications than a QD schedule.